InvestorsHub Logo
Followers 18
Posts 899
Boards Moderated 0
Alias Born 11/19/2010

Re: None

Tuesday, 09/16/2014 8:55:54 AM

Tuesday, September 16, 2014 8:55:54 AM

Post# of 106839
NEWS OUT: Bioheart Announces Grand Opening of Facility in South Africa

SUNRISE, FL, Sep 16, 2014 (Marketwired via COMTEX) -- Bioheart, Inc. (otcqb:BHRT), a biotechnology company focused on the discovery, development and, subject to regulatory approval, commercialization of autologous cell therapies for the treatment of degenerative diseases, announces the grand opening the laboratory and clinic in South Africa.

Bioheart previously announced the joint venture with Dr. Walter Bell last quarter. The facilities in South Africa opening this week will be able to provide cell therapies in the clinic as well as cell culture expansion and cryopreservation to local patients. Bioheart can multiply and preserve an individual's cells in sub-zero temperatures for future treatments as required.

Kristin Comella, Bioheart's Chief Science Officer, who is attending the grand opening, said, "We are so thrilled to open this facility in just over 3 months. There are millions of patients in South Africa and neighboring countries who can benefit from regenerative medicine."

Bioheart's partnership will establish a critical relationship with the South African government and the joint venture will work closely with the Ministry of Health to make Bioheart protocols part of the standard of care for patients in South Africa and neighboring countries. Bioheart has provided the necessary training and expertise to transfer Bioheart therapies to the new facility.

Bioheart will assume 49% ownership of the new entity. Dr. Walter Bell and his team will offer these therapies to the more than 51 million people living in South Africa as well as being a premier site for medical tourism.



http://www.marketwatch.com/story/bioheart-announces-grand-opening-of-facility-in-south-africa-2014-09-16